Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human rhinovirus 3 at 3.0 A resolution

R Zhao1, D C Pevear, M J Kremer

  • 1Department of Biological Sciences, Purdue University, West Lafayette, IN 47907-1392, USA.

Structure (London, England : 1993)
|October 15, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tobramycin pharmacokinetics in patients with cystic fibrosis before and after bilateral lung transplantation.

Transplant infectious disease : an official journal of the Transplantation Society·2011
Same author

Detection of membrane protein two-dimensional crystals in living cells.

Biophysical journal·2010
Same author

Climate change and the integrity of science.

Science (New York, N.Y.)·2010
Same author

Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion.

Journal of virology·2009
Same author

Structure of southern bean mosaic virus at 2.8 A resolution.

Nature·2009
Same author

Protein kinase G phosphorylates mosquito-borne flavivirus NS5.

Journal of virology·2009

Human rhinoviruses (HRV) in antiviral group A, like HRV3 and HRV14, share similar structures and lack pocket factors. This structural similarity may extend to other group A viruses, influencing their stability and pathogenicity.

Area of Science:

  • Virology
  • Structural Biology
  • Drug Discovery

Background:

  • Human rhinoviruses (HRV) cause the common cold and are classified into major/minor receptor groups and antiviral groups A/B.
  • Previous studies determined structures of HRV14, HRV16, and HRV1A, noting HRV14's unique lack of a pocket factor.
  • HRV3 was selected for study as it represents the drug sensitivity of most HRV serotypes and belongs to antiviral group A.

Purpose of the Study:

  • To investigate the structural and sequence similarities between HRV3 and HRV14.
  • To understand the implications of these similarities for HRV classification and antiviral drug development.

Main Methods:

  • X-ray crystallography was used to determine the structure of HRV3.
  • The structure of HRV3 in complex with the antiviral compound WIN56291 was determined.

Related Experiment Videos

  • Sequence and structural comparisons were made between HRV3, HRV14, and other known HRV structures.

    • Main Results:

    • HRV3 exhibits high sequence and structural similarity to HRV14.
    • Crystallized HRV3, like HRV14, lacks a bound pocket factor.
    • The structure of the HRV3-WIN56291 complex mirrors the HRV14-WIN56291 complex.

    Conclusions:

    • Structural and sequence similarities suggest that rhinoviruses within the same antiviral group (A) share common characteristics.
    • Group B HRVs may possess pocket factors and ordered N-terminal helices in VP1, contributing to increased viral stability and pathogenicity.
    • Understanding these structural differences can inform the development of targeted antiviral therapies.